Reuters logo
BRIEF-Synact Pharma Q2 pre-tax loss at SEK 5.2 million
August 31, 2017 / 12:48 PM / 3 months ago

BRIEF-Synact Pharma Q2 pre-tax loss at SEK 5.2 million

Aug 31 (Reuters) - SYNACT PHARMA AB:

* Q2 PRE-TAX LOSS SEK 5.2 MILLION VERSUS SEK 5.6 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below